Inventor · disambiguated record
Jon Loren
Also filed as: LOREN JON · LOREN JON C · LOREN JON CHRISTOPHER
20 granted patents·8 pending applications·328 citations·filing 2006–2022
94Inventor score
Top patents by PatentIndex Score
28 records- 0196US9102671B2Compounds and compositions as TRK inhibitorsMOLTENI VALENTINA·Filed 2012·Granted Aug 11, 2015·80 cites·19 claims
- 0296US8338417B2Compounds and compositions as c-kit and PDGFR kinase inhibitorsLI XIAOLIN·Filed 2008·Granted Dec 25, 2012·86 cites·8 claims
- 0393US8637516B2Compounds and compositions as TRK inhibitorsFAN YI·Filed 2011·Granted Jan 28, 2014·82 cites·29 claims
- 0489US8569283B2Compounds and compositions as c-Kit kinase inhibitorsMOLTENI VALENTINA·Filed 2012·Granted Oct 29, 2013·12 cites·26 claims
- 0589US8288540B22-heteroarylamino-pyrimidine derivatives as kinase inhibitorsCHIANELLI DONATELLA·Filed 2008·Granted Oct 16, 2012·20 cites·15 claims
- 0689US7678792B2Compositions and methods for modulating c-kit and PDGFR receptorsIRM LLC·Filed 2007·Granted Mar 16, 2010·13 cites·17 claims
- 0782US8293757B25-(4-(haloalkoxy)phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitorsMOLTENI VALENTINA·Filed 2008·Granted Oct 23, 2012·6 cites·7 claims
- 0881US9199981B2Compounds and compositions as C-kit kinase inhibitorsYEH VINCE·Filed 2012·Granted Dec 1, 2015·9 cites·26 claims
- 0981US7592349B2Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptorsIRM LLC·Filed 2007·Granted Sep 22, 2009·3 cites·14 claims
- 1081US7563894B2Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptorsIRM LLC·Filed 2007·Granted Jul 21, 2009·3 cites·10 claims
- 1178US9023839B2Compounds and compositions as c-kit kinase inhibitorsMOLTENI VALENTINA·Filed 2014·Granted May 5, 2015·3 cites·24 claims
- 1278US7514447B2Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptorsIRM LLC·Filed 2006·Granted Apr 7, 2009·2 cites·6 claims
- 1376US8754071B2Compounds and compositions as c-kit kinase inhibitorsMOLENTI VALENTINA·Filed 2013·Granted Jun 17, 2014·5 cites·24 claims
- 1475US7638523B2Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptorsIRM LLC·Filed 2007·Granted Dec 29, 2009·1 cites·14 claims
- 1574US8106068B2Compositions and methods for modulating c-kit and PDGFR receptorsLIU ZUOSHENG·Filed 2009·Granted Jan 31, 2012·3 cites·6 claims
- 1667US2009264649A1Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptorsIRM LLC·Filed 2009·Application pending·0 cites
- 1762US2022340573A11,2,4-oxadiazole derivatives as liver x receptor agonistsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1859US11427586B21,2,4-oxadiazole derivatives as liver X receptor agonistsNOVARTIS AG·Filed 2020·Granted Aug 30, 2022·0 cites·21 claims
- 1956US9073921B2Salt forms of bicyclic heterocyclic derivativesBRUCE IAN·Filed 2014·Granted Jul 7, 2015·0 cites·17 claims
- 2055US2024238305A1Formulations of 3-((3-(4-(2-(isobutylsulfonyl)phenoxy)-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-5-yl)methyl)-5,5-dimethyl-1-(2-morpholinoethyl)imidazolidine-2,4-dioneNOVARTIS AG·Filed 2022·Application pending·0 cites
- 2151US9751876B2Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertensionNOVARTIS AG·Filed 2014·Granted Sep 5, 2017·0 cites·18 claims
- 2251US8278452B2Heterocyclic compounds and compositions as c-kit and PDGFR kinase inhibitorsCHIANELLI DONATELLA·Filed 2009·Granted Oct 2, 2012·0 cites·14 claims
- 2347US2010048539A1Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2007·Application pending·0 cites
- 2445US8883819B2Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertensionBRUCE IAN·Filed 2012·Granted Nov 11, 2014·0 cites·20 claims
- 2542US2009227571A1Androgen Receptor Modulator Compounds and MethodsLIGAND PHARM INC·Filed 2006·Application pending·0 cites
- 2641US2015051206A1Compounds and compositions as c-kit kinase inhibitorsLOREN JON·Filed 2012·Application pending·0 cites
- 2741US2015011508A1Compounds and compositions as c-kit kinase inhibitorsLIU XIAODONG·Filed 2012·Application pending·0 cites
- 2833US2014206682A1Compounds and compositions as pdgfr kinase inhibitorsLIANG FANG·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →